Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:37 AM
Ignite Modification Date:
2025-12-25 @ 4:37 AM
NCT ID:
NCT00406718
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV criteria, as determined on the basis of the Structured Clinical Interview for Diagnosis (SCID-P)
* Receiving treatment with an oral atypical antipsychotic medication other than clozapine (e.g., risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, or others as they are FDA approved)
* Assumes some responsibility for taking own medications
* Able to provide evidence of a stable living environment (e.g., individual apartment, family home, or board and care facility) within 3 months prior to study entry and no plans to move in the next year
* Intact visual and auditory ability as determined by a computerized screening battery
* Ability to read at the 5th grade level or higher based upon score on the Wide Range Achievement Test (WRAT)
* Able to understand and complete rating scales and neuropsychological testing
* Working telephone present in the home
Exclusion Criteria:
* History of significant head trauma, seizure disorder, or mental retardation
* Alcohol or drug abuse or dependence within 3 months prior to study entry
* Currently being treated by an assertive community treatment (ACT) team
* History of violence within 1 year prior to study entry
* Any hospitalizations within 3 months prior to study entry
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00406718
Study Brief:
Protocol Section:
NCT00406718